CEO-LED ADVOCACY WINS $3-MILLION FINANCING...

NEWS RELEASE CEO-LED ADVOCACY WINS $3-MILLION FINANCING FOR EXPORT-FOCUSED ONTARIO BIOSCIENCE COMPANIES New treatments and technologies for common diseases have global market potential TORONTO (July 27) – Four Ontario bioscience companies engaged in the development of groundbreaking new drug therapies and a diagnostic screening technology have each been awarded up to $1 million in financing to fund clinical trials and...

Commercialization Success OBEST...

With the global economy still in recovery two years after the economic downturn, Ontario’s bioscience industry and a universe if pan- Ontario stakeholders seized the opportunity to contribute to Ontario’s economic growth and developed a comprehensive, implementable plan for a vibrant biosciences industry. Developed by OBIO, the plan is named, OBEST (Ontario Biosciences Economic Strategy Team) and articles...